| IκBζ: an emerging player in cancer M Willems, N Dubois, L Musumeci, V Bours, PA Robe Oncotarget 7 (40), 66310, 2016 | 56 | 2016 |
| Constitutive activation of casein kinase 2 in glioblastomas: absence of class restriction and broad therapeutic potential N Dubois, M Willems, MT Nguyen-Khac, J Kroonen, N Goffart, M Deprez, ... International Journal of Oncology 48 (6), 2445-2452, 2016 | 20 | 2016 |
| Training of radiotherapy professionals: status, content, satisfaction and improvement suggestions in the Greater Region N Dubois, A Nguyet Diep, A Ghuysen, J Declaye, AF Donneau, G Vogin, ... BMC Medical Education 22 (1), 485, 2022 | 9 | 2022 |
| “Debriefing and Organizational Lessons Learned”(DOLL): a qualitative study to develop a classification framework for reporting clinical debriefing results M Paquay, N Dubois, AN Diep, G Graas, T Sassel, J Piazza, JC Servotte, ... Frontiers in Medicine 9, 882326, 2022 | 8 | 2022 |
| Exploring the feasibility of the Magnet Hospital concept within a European university nursing department: a mixed-methods study M Paquay, JM Boulanger, M Locquet, N Dubois, A Ghuysen Contemporary nurse 57 (3-4), 187-201, 2021 | 5 | 2021 |
| The COVID-19 status of patients is an essential determinant for decision-making by radiation oncologists: a European survey SB Mustapha, P Simoni, N Dubois, N Jansen, F Lakosi, AS Mota, ... Cureus 14 (3), 2022 | 3 | 2022 |
| I-Kappa-B kinase-epsilon activates nuclear factor-kappa B and STAT5B and supports glioblastoma growth but amlexanox shows little therapeutic potential in these tumors N Dubois, S Berendsen, A Henry, M Nguyen, V Bours, P Robe Cancer Translational Medicine 4 (1), 2018 | 2 | 2018 |
| STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas N Dubois, S Berendsen, K Tan, L Schoysmans, W Spliet, T Seute, V Bours, ... International Journal of Oncology 61 (4), 1-9, 2022 | 1 | 2022 |
| CS-36 IkappaB ZETA OVEREXPRESSION DRIVES HUMAN GLIOMA RESISTANCE TO NECROPTOSIS M Willems, J Kroonen, N Dubois, S Berendsen, B Nguyen, M Bredel, ... Neuro-oncology 16 (suppl_5), v58-v59, 2014 | 1 | 2014 |
| Impact of virtual reality training in disaster medicine S Chevalier, N Dubois Archives of Public Health, 2021 | | 2021 |
| Simulation-based training development to strive for excellence in radiation oncologist's education N DUBOIS, S CUCCHIARO, S BEN MUSTAPHA, M NOEL, ... | | 2019 |
| Involvement of Ikbζ in glioblastomas and its potential implication in radioresistance N Dubois, M Willems, J Kroonen, S Berendsen, W Van Hecke, M Bredel, ... 28th EORTC-NCI-AACR symposium on" Molecular targets and cancer therapeutics", 2016 | | 2016 |
| Development of injectable liposomes entrapping apigenin for brain-targeted delivery as glioblastoma treatment R Karim, C Pallazo, N Dubois, V Bours, C Passirani-Malleret, B Evrard, ... 4th Congress on Innovation in Drug Delivery Site-Specific Drug Delivery, 2016 | | 2016 |
| Involvement of Iκbζ in glioblastomas and its potential implication in radioresistance N Dubois, M Willems, J Kroonen, S Berendsen, W Van Hecke, M Bredel, ... European Journal of Cancer 1 (69), S21, 2016 | | 2016 |
| Stealth Liposome and Drug-In-Cyclodextrin-In-Liposome Formulations Entrapping Apigenin as Novel Therapy for Glioblastoma R Karim, C Palazzo, N Dubois, V Bours, C Passirani, B Evrard, G Piel 'From drug development to target drug'-UniGR workshop on Biomedicine, 2015 | | 2015 |
| Liposomes entrapping apigenin for the treatment of glioblastoma R Karim, C Palazzo, N Dubois, V Bours, C Passirani, G Piel 2015 UKICRS Workshop & Symposium, 2015 | | 2015 |
| PEGylated liposomes containing apigenin for the treatment of glioblastoma R Karim, C Palazzo, N Dubois, V Bours, C Passirani, G Piel 1st European conference on Pharmaceutics Reims 2015, 2015 | | 2015 |
| Design of Liposomes Entrapping Apigenin-A Novel Approach for Glioblastoma Therapy R Karim, C Palazzo, N Dubois, A Frère, V Bours, C Passirani, B Evrard, ... 2015 AAPS Annual Meeting and Exposition, 2015 | | 2015 |
